The rapidly spreading COVID-19 pandemic, first identified in China in December 2019,[@bib1] caused an outbreak in the medical staff of our Department of Angiology and Vascular Surgery. The first positive case of COVID-19 (the head of the department) was diagnosed on March 13, when the country counted just 112 cases.[@bib2] High-risk contacts had to go through quarantine, with five more colleagues testing positive in the subsequent week. In the blink of an eye, the department suffered a 55% reduction of medical staff (62.5% specialist reduction).

Besides the contingency measures already implemented, such as suspension of all ambulatory activity and a reduction of ≈73% in operating room time, a tailored contingency plan was mandatory to rationalize the scarce medical resources of our department---a pioneer attitude that was in general accordance with the posteriorly issued recommendations.

Six weeks have passed, and thankfully, all of our infected colleagues had a good recovery; only one needed intensive care support but has already been discharged. During this 6-week period, there were three infected patients, without medical staff cross-infection. Even with this huge human resource constraint, the department fulfilled all planned activities.

Retrospectively reviewing our databases and comparing this 6-week period with the prior 6 weeks, we could verify that the ward occupancy rate decreased from 101.41% to 64.61%, while outpatient clinic visits decreased 87.7% (≈83.7% appointments performed in this pandemic era were via telemedicine). Furthermore, there was a huge surgical impact with ≈87% decrease, with a higher reduction in elective surgery being registered, as expected (≈90%). However, even urgent interventions had a significant reduction, ≈57%, raising concern as to whether fear of COVID-19 infection was preventing patients from coming to the emergency department.[@bib3]

With a successful flattening of the curve and 23,392 confirmed cases in Portugal (880 deaths and 1277 recovered cases to this date[@bib2]), a "new normal" is being redefined. Nonetheless, with a "second coming" of COVID-19 and an expected wave of vascular patients resulting from prolonged waiting times with a possibly deteriorated clinical status, vascular practice will have to evolve pliably and efficiently.
